A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir

Pediatr Infect Dis J. 1999 Jul;18(7):650-2. doi: 10.1097/00006454-199907000-00019.
No abstract available

MeSH terms

  • Adolescent
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count*
  • CD4-CD8 Ratio
  • CD8-Positive T-Lymphocytes / immunology*
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / physiology*
  • Humans
  • Infant
  • Lymphocyte Count
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use*
  • Virus Replication

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Ritonavir